logo
Select company
Select metric
94.33%Free Cash Flow to Operating Cash Flow
VS
Market
78
Sector
78
Industry
40
History
95
$ 6.56Close
$ 3.79 - $ 11.7 52-Week Range
Ticker Information

Ticker

CSBR

Company Name

CHAMPIONS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CHAMPIONS ONCOLOGY INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CSBR - FCF/OCF Historical data
DateFree Cash FlowFree Cash Flow to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 7.24M94.33%$ 7.67M
3/31/2025$ 7M94.73%$ 7.39M
12/31/2024$ -1.32M0%$ -1.3M
9/30/2024$ -2.82M0%$ -2.71M
6/30/2024$ -2M0%$ -1.83M
3/31/2024$ -6.97M0%$ -6.14M
12/31/2023$ -6.72M0%$ -5.01M
9/30/2023$ -4.86M0%$ -2.52M
6/30/2023$ -2.61M-1482.95%$ 176K
3/31/2023$ 1.1M27.69%$ 3.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CHAMPIONS ONCOLOGY INC's latest trailing twelve months (TTM) FCF/OCF stands at 2.21%.
  • Over the past 5 years, CHAMPIONS ONCOLOGY INC's average FCF/OCF has been -93.24%.
  • The median FCF/OCF for CHAMPIONS ONCOLOGY INC during this period was 52.05%
  • CHAMPIONS ONCOLOGY INC reached its highest FCF/OCF over the past 5 years at 94.73%.
  • The lowest FCF/OCF recorded by CHAMPIONS ONCOLOGY INC in the same timeframe -1482.95%

CHAMPIONS ONCOLOGY INC's FCF/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF/OCF Benchmarks
CompanyFCF/OCF
PLX : PROTALIX BIOTHERAPEUTICS INC -CELU : CELULARITY INC -SPRO : SPERO THERAPEUTICS INC -THTX : THERATECHNOLOGIES INC 99.84%IVVD : INVIVYD INC -DOMH : DOMINARI HOLDINGS INC -BDTX : BLACK DIAMOND THERAPEUTICS INC 100.44%FBIO : FORTRESS BIOTECH INC -ENTA : ENANTA PHARMACEUTICALS INC -SGMO : SANGAMO THERAPEUTICS INC -

Definition of Free Cash Flow to Operating Cash Flow

[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
FCF / CF - Operations
(=) FCF/OCF
FCF/OCF for CHAMPIONS ONCOLOGY INC is calculated as follows: FCF [ $ 66K ] / CF - Operations [ $ 2.99M ]
(=) FCF/OCF [ 2.21% ]

CSBR - Free Cash Flow to Operating Cash Flow, Last 5 years

-1482.95%

Minimum

Jun 30, 2023

94.73%

Maximum

Mar 31, 2025

-93.24%

Average

52.05%

Median

FCF/OCF Benchmark Analysis

The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.45% with a standard deviation of 29.09%.
The following table provides additional summary stats:
FCF/OCF in the Market:
filtered constituents2.51K
min-23%
max171.58%
average71.45%
median80.76%
std29.09%